Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-proven rare case of minimal change nephrotic syndrome...

Full description

Bibliographic Details
Main Authors: Hisato Shima, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Chiaki Masaki, Hiroaki Tada, Norimichi Takamatsu, Kazuhiko Kawahara, Kazuyoshi Okada, Toshio Doi, Jun Minakuchi, Shu Kawashima
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059519300202

Internet

http://www.sciencedirect.com/science/article/pii/S2590059519300202

Similar Items